Cingulate

CINGPhase 3

Market Cap

$80.7M

Focus

Biotech

USD 7.38503.82 (-98.56%)

Historical price data

6 drugs in pipeline, 3 in Phase 3

Drug	Indication	Stage
CTx-1301-Dexmethylphenidate 12.5 mg (titration only) + CTx-1301-Dexmethylphenida...	ADHD	Phase 3
CTx-1301 - Dexmethylphenidate 6.25mg + CTx-1301 - Dexmethylphenidate 12.5mg + CT...	ADHD	Phase 3
CTx-1301 - Dexmethylphenidate 25mg + CTx-1301 - Dexmethylphenidate 37.5mg + CTx-...	ADHD	Phase 3
Dexmethylphenidate 5 Mg Oral Capsule, Extended Release + Dexmethylphenidate 6.25...	ADHD	Phase 1/2
Dexmethylphenidate	Healthy Volunteers in Fed and Fasted State	Phase 1